BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16836559)

  • 1. Antithrombin reduces monocyte and neutrophil CD11b up regulation in addition to blocking platelet activation during extracorporeal circulation.
    Rinder CS; Rinder HM; Smith MJ; Fitch JC; Tracey JB; Chandler WL; Rollins SA; Smith BR
    Transfusion; 2006 Jul; 46(7):1130-7. PubMed ID: 16836559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukocyte effects of C5a-receptor blockade during simulated extracorporeal circulation.
    Rinder CS; Smith MJ; Rinder HM; Cortright DN; Brodbeck RM; Krause JE; Smith BR
    Ann Thorac Surg; 2007 Jan; 83(1):146-52. PubMed ID: 17184649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nafamostat preserves neutrophil deformability and reduces microaggregate formation during simulated extracorporeal circulation.
    Hiramatsu Y; Homma S; Sato Y; Sato S; Matsuzaki K; Shigeta O; Sakakibara Y
    Ann Thorac Surg; 2005 Apr; 79(4):1326-32. PubMed ID: 15797071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion.
    Wachtfogel YT; Kucich U; Hack CE; Gluszko P; Niewiarowski S; Colman RW; Edmunds LH
    J Thorac Cardiovasc Surg; 1993 Jul; 106(1):1-9; discussion 9-10. PubMed ID: 7686593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sivelestat reduces inflammatory mediators and preserves neutrophil deformability during simulated extracorporeal circulation.
    Matsuzaki K; Hiramatsu Y; Homma S; Sato S; Shigeta O; Sakakibara Y
    Ann Thorac Surg; 2005 Aug; 80(2):611-7. PubMed ID: 16039215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombin and human plasma kallikrein inhibition during simulated extracorporeal circulation block platelet and neutrophil activation.
    Wachtfogel YT; Kettner C; Hack CE; Nuijens JH; Reilly TM; Knabb RM; Kucich U; Niewiarowski S; Edmunds LH; Colman RW
    Thromb Haemost; 1998 Oct; 80(4):686-91. PubMed ID: 9798991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiesterase type 4 inhibitor rolipram inhibits activation of monocytes during extracorporeal circulation.
    Sato Y; Hiramatsu Y; Homma S; Sato M; Sato S; Endo S; Sohara Y
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):346-50. PubMed ID: 16077397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational activation of CD11b without shedding of L-selectin on circulating human neutrophils.
    Orr Y; Taylor JM; Cartland S; Bannon PG; Geczy C; Kritharides L
    J Leukoc Biol; 2007 Nov; 82(5):1115-25. PubMed ID: 17675559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of C3 cleavage in monocyte activation during extracorporeal circulation.
    Rinder CS; Rinder HM; Johnson K; Smith M; Lee DL; Tracey J; Polack G; Higgins P; Yeh CG; Smith BR
    Circulation; 1999 Aug; 100(5):553-8. PubMed ID: 10430771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective blockade of membrane attack complex formation during simulated extracorporeal circulation inhibits platelet but not leukocyte activation.
    Rinder CS; Rinder HM; Smith MJ; Tracey JB; Fitch J; Li L; Rollins SA; Smith BR
    J Thorac Cardiovasc Surg; 1999 Sep; 118(3):460-6. PubMed ID: 10469960
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of factor Xa inhibitors on thrombin formation and complement and neutrophil activation during in vitro extracorporeal circulation.
    Gikakis N; Khan MM; Hiramatsu Y; Gorman JH; Hack CE; Sun L; Rao AK; Niewiarowski S; Colman RW; Edmunds LH
    Circulation; 1996 Nov; 94(9 Suppl):II341-6. PubMed ID: 8901772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of neutrophils and monocytes by a leukocyte-depleting filter used throughout cardiopulmonary bypass.
    Ilmakunnas M; Pesonen EJ; Ahonen J; Rämö J; Siitonen S; Repo H
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):851-9. PubMed ID: 15821654
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte- and monocyte-platelet adhesion index in coronary and peripheral blood after extracorporeal circulation and reperfusion.
    Sbrana S; Buffa M; Bevilacqua S; Spiller D; Parri MS; Gianetti J; De Filippis R; Clerico A
    Cytometry B Clin Cytom; 2007 May; 72(3):215-22. PubMed ID: 17133378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nafamostat mesilate, a broad spectrum protease inhibitor, modulates platelet, neutrophil and contact activation in simulated extracorporeal circulation.
    Sundaram S; Gikakis N; Hack CE; Niewiarowski S; Edmunds LH; Koneti Rao A; Sun L; Cooper SL; Colman RW
    Thromb Haemost; 1996 Jan; 75(1):76-82. PubMed ID: 8713783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation.
    Rinder CS; Rinder HM; Smith BR; Fitch JC; Smith MJ; Tracey JB; Matis LA; Squinto SP; Rollins SA
    J Clin Invest; 1995 Sep; 96(3):1564-72. PubMed ID: 7657827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha 1-antitrypsin Pittsburgh (Met358-->Arg) inhibits the contact pathway of intrinsic coagulation and alters the release of human neutrophil elastase during simulated extracorporeal circulation.
    Wachtfogel YT; Bischoff R; Bauer R; Hack CE; Nuijens JH; Kucich U; Niewiarowski S; Edmunds LH; Colman RW
    Thromb Haemost; 1994 Dec; 72(6):843-7. PubMed ID: 7740452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of complement C3 opsonization, C5a receptor, and CD14 in E. coli-induced up-regulation of granulocyte and monocyte CD11b/CD18 (CR3), phagocytosis, and oxidative burst in human whole blood.
    Brekke OL; Christiansen D; Fure H; Fung M; Mollnes TE
    J Leukoc Biol; 2007 Jun; 81(6):1404-13. PubMed ID: 17389579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplification of the inflammatory response: adhesion molecules associated with platelet/white cell responses.
    Rinder C; Fitch J
    J Cardiovasc Pharmacol; 1996; 27 Suppl 1():S6-12. PubMed ID: 8938278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects on blood compatibility in vitro by combining a direct P2Y12 receptor inhibitor and heparin coating of stents.
    Christensen K; Larsson R; Emanuelsson H; Elgue G; Larsson A
    Platelets; 2006 Aug; 17(5):318-27. PubMed ID: 16928604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of neutrophil granulocytes in an in vitro model of a cardiopulmonary bypass.
    Asberg AE; Videm V
    Artif Organs; 2005 Dec; 29(12):927-36. PubMed ID: 16305648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.